David Hurley

P-K Chemicals Ltd. distributes chemical and food products. The company is headquartered in Ireland.

Net Transmit & Receive SL develops collaboration software for remote support and access. It provides cloud-based remote desktop, chat, information technology, automation software solutions for clients in education, financial services, government, manufacturing, retail, technology sectors. The firm offers remote support for customers, employees, access to pcs, macs and enterprise mobility management. The company was founded in 2000 and is headquartered in Barcelona, Spain.

Part of SAS Rue la Boétie, Merrion Fleet Management Ltd. is an Irish company that offers long-term vehicle leasing and fleet management solutions. The company is based in Co Dublin, Ireland. The company was founded in 1999. David Wilkinson has been the CEO of the company since 2002.

Azur Pharma Ltd. manufactures pharmaceutical products. It offers branded generic prescription drugs, antibiotics and medicines in multiple therapeutic areas. The company was founded in May, 2005 and is headquartered in Dublin, IE

KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY.

Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland.

Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland.